Tumour-derived C3a was reported to polarize tumour-associated macrophages (TAMs) towards an immunosuppressive M2-like phenotype and to mediate the suppression of T-cell proliferation through the C3a-C3aR axis in a syngeneic mouse model derived from mouse melanoma and in colon and lung cancer cells. Here, C3 is linked to neoplasm.